<?xml version='1.0' encoding='utf-8'?>
<document id="27119576"><sentence text="Pharmacokinetic drug-drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel-ethinyl estradiol in healthy subjects."><entity charOffset="63-74" id="DDI-PubMed.27119576.s1.e0" text="angiotensin" /><entity charOffset="111-121" id="DDI-PubMed.27119576.s1.e1" text="omeprazole" /><entity charOffset="123-132" id="DDI-PubMed.27119576.s1.e2" text="metformin" /><entity charOffset="136-150" id="DDI-PubMed.27119576.s1.e3" text="levonorgestrel" /><entity charOffset="151-168" id="DDI-PubMed.27119576.s1.e4" text="ethinyl estradiol" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e0" e2="DDI-PubMed.27119576.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e0" e2="DDI-PubMed.27119576.s1.e1" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e0" e2="DDI-PubMed.27119576.s1.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e0" e2="DDI-PubMed.27119576.s1.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e0" e2="DDI-PubMed.27119576.s1.e4" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e1" e2="DDI-PubMed.27119576.s1.e1" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e1" e2="DDI-PubMed.27119576.s1.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e1" e2="DDI-PubMed.27119576.s1.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e1" e2="DDI-PubMed.27119576.s1.e4" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e2" e2="DDI-PubMed.27119576.s1.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e2" e2="DDI-PubMed.27119576.s1.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e2" e2="DDI-PubMed.27119576.s1.e4" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e3" e2="DDI-PubMed.27119576.s1.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s1.e3" e2="DDI-PubMed.27119576.s1.e4" /></sentence><sentence text="LCZ696 is a novel angiotensin receptor neprilysin inhibitor in development for the treatment of cardiovascular diseases"><entity charOffset="18-29" id="DDI-PubMed.27119576.s2.e0" text="angiotensin" /></sentence><sentence text=" Here, we assessed the potential for pharmacokinetic drug-drug interaction of LCZ696 (400 mg, single dose or once daily [q" /><sentence text="d" /><sentence text="]) when co-administered with omeprazole 40 mg q"><entity charOffset="29-39" id="DDI-PubMed.27119576.s5.e0" text="omeprazole" /></sentence><sentence text="d" /><sentence text=" (n = 28) or metformin 1000 mg q"><entity charOffset="13-22" id="DDI-PubMed.27119576.s7.e0" text="metformin" /></sentence><sentence text="d" /><sentence text=" (n = 27) or levonorgestrel-ethinyl estradiol 150/30 μg single dose (n = 24) in three separate open-label, single-sequence studies in healthy subjects"><entity charOffset="13-27" id="DDI-PubMed.27119576.s9.e0" text="levonorgestrel" /><entity charOffset="28-45" id="DDI-PubMed.27119576.s9.e1" text="ethinyl estradiol" /><pair ddi="false" e1="DDI-PubMed.27119576.s9.e0" e2="DDI-PubMed.27119576.s9.e0" /><pair ddi="false" e1="DDI-PubMed.27119576.s9.e0" e2="DDI-PubMed.27119576.s9.e1" /></sentence><sentence text=" Pharmacokinetic parameters of LCZ696 analytes (sacubitril, LBQ657, and valsartan), metformin, and levonorgestrel-ethinyl estradiol were assessed"><entity charOffset="48-58" id="DDI-PubMed.27119576.s10.e0" text="sacubitril" /><entity charOffset="60-66" id="DDI-PubMed.27119576.s10.e1" text="LBQ657" /><entity charOffset="72-81" id="DDI-PubMed.27119576.s10.e2" text="valsartan" /><entity charOffset="84-93" id="DDI-PubMed.27119576.s10.e3" text="metformin" /><entity charOffset="99-113" id="DDI-PubMed.27119576.s10.e4" text="levonorgestrel" /><entity charOffset="114-131" id="DDI-PubMed.27119576.s10.e5" text="ethinyl estradiol" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e0" e2="DDI-PubMed.27119576.s10.e0" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e0" e2="DDI-PubMed.27119576.s10.e1" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e0" e2="DDI-PubMed.27119576.s10.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e0" e2="DDI-PubMed.27119576.s10.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e0" e2="DDI-PubMed.27119576.s10.e4" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e0" e2="DDI-PubMed.27119576.s10.e5" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e1" e2="DDI-PubMed.27119576.s10.e1" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e1" e2="DDI-PubMed.27119576.s10.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e1" e2="DDI-PubMed.27119576.s10.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e1" e2="DDI-PubMed.27119576.s10.e4" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e1" e2="DDI-PubMed.27119576.s10.e5" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e2" e2="DDI-PubMed.27119576.s10.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e2" e2="DDI-PubMed.27119576.s10.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e2" e2="DDI-PubMed.27119576.s10.e4" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e2" e2="DDI-PubMed.27119576.s10.e5" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e3" e2="DDI-PubMed.27119576.s10.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e3" e2="DDI-PubMed.27119576.s10.e4" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e3" e2="DDI-PubMed.27119576.s10.e5" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e4" e2="DDI-PubMed.27119576.s10.e4" /><pair ddi="false" e1="DDI-PubMed.27119576.s10.e4" e2="DDI-PubMed.27119576.s10.e5" /></sentence><sentence text=" Omeprazole did not alter the AUCinf of sacubitril and pharmacokinetics of LBQ657; however, 7% decrease in the Cmax of sacubitril, and 11% and 13% decreases in AUCinf and Cmax of valsartan were observed"><entity charOffset="1-11" id="DDI-PubMed.27119576.s11.e0" text="Omeprazole" /><entity charOffset="119-129" id="DDI-PubMed.27119576.s11.e1" text="sacubitril" /><entity charOffset="179-188" id="DDI-PubMed.27119576.s11.e2" text="valsartan" /><pair ddi="false" e1="DDI-PubMed.27119576.s11.e0" e2="DDI-PubMed.27119576.s11.e0" /><pair ddi="false" e1="DDI-PubMed.27119576.s11.e0" e2="DDI-PubMed.27119576.s11.e1" /><pair ddi="false" e1="DDI-PubMed.27119576.s11.e0" e2="DDI-PubMed.27119576.s11.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s11.e1" e2="DDI-PubMed.27119576.s11.e1" /><pair ddi="false" e1="DDI-PubMed.27119576.s11.e1" e2="DDI-PubMed.27119576.s11.e2" /></sentence><sentence text=" Co-administration of LCZ696 with metformin had no significant effect on the pharmacokinetics of LBQ657 and valsartan; however, AUCtau,ss and Cmax,ss of metformin were decreased by 23%"><entity charOffset="34-43" id="DDI-PubMed.27119576.s12.e0" text="metformin" /><entity charOffset="108-117" id="DDI-PubMed.27119576.s12.e1" text="valsartan" /><entity charOffset="153-162" id="DDI-PubMed.27119576.s12.e2" text="metformin" /><pair ddi="false" e1="DDI-PubMed.27119576.s12.e0" e2="DDI-PubMed.27119576.s12.e0" /><pair ddi="false" e1="DDI-PubMed.27119576.s12.e0" e2="DDI-PubMed.27119576.s12.e1" /><pair ddi="false" e1="DDI-PubMed.27119576.s12.e0" e2="DDI-PubMed.27119576.s12.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s12.e1" e2="DDI-PubMed.27119576.s12.e1" /><pair ddi="false" e1="DDI-PubMed.27119576.s12.e1" e2="DDI-PubMed.27119576.s12.e2" /></sentence><sentence text=" Co-administration of LCZ696 with levonorgestrel-ethinyl estradiol had no effect on the pharmacokinetics of ethinyl estradiol and LBQ657 or AUCinf of levonorgestrel"><entity charOffset="34-48" id="DDI-PubMed.27119576.s13.e0" text="levonorgestrel" /><entity charOffset="49-66" id="DDI-PubMed.27119576.s13.e1" text="ethinyl estradiol" /><entity charOffset="108-125" id="DDI-PubMed.27119576.s13.e2" text="ethinyl estradiol" /><entity charOffset="130-136" id="DDI-PubMed.27119576.s13.e3" text="LBQ657" /><entity charOffset="150-164" id="DDI-PubMed.27119576.s13.e4" text="levonorgestrel" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e0" e2="DDI-PubMed.27119576.s13.e0" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e0" e2="DDI-PubMed.27119576.s13.e1" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e0" e2="DDI-PubMed.27119576.s13.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e0" e2="DDI-PubMed.27119576.s13.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e0" e2="DDI-PubMed.27119576.s13.e4" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e1" e2="DDI-PubMed.27119576.s13.e1" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e1" e2="DDI-PubMed.27119576.s13.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e1" e2="DDI-PubMed.27119576.s13.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e1" e2="DDI-PubMed.27119576.s13.e4" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e2" e2="DDI-PubMed.27119576.s13.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e2" e2="DDI-PubMed.27119576.s13.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e2" e2="DDI-PubMed.27119576.s13.e4" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e3" e2="DDI-PubMed.27119576.s13.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s13.e3" e2="DDI-PubMed.27119576.s13.e4" /></sentence><sentence text=" The Cmax of levonorgestrel decreased by 15%, and AUCtau,ss and Cmax,ss of valsartan decreased by 14% and 16%, respectively"><entity charOffset="13-27" id="DDI-PubMed.27119576.s14.e0" text="levonorgestrel" /><entity charOffset="75-84" id="DDI-PubMed.27119576.s14.e1" text="valsartan" /><pair ddi="false" e1="DDI-PubMed.27119576.s14.e0" e2="DDI-PubMed.27119576.s14.e0" /><pair ddi="false" e1="DDI-PubMed.27119576.s14.e0" e2="DDI-PubMed.27119576.s14.e1" /></sentence><sentence text=" Co-administration of LCZ696 with omeprazole, metformin, or levonorgestrel-ethinyl estradiol was not associated with any clinically relevant pharmacokinetic drug interactions"><entity charOffset="34-44" id="DDI-PubMed.27119576.s15.e0" text="omeprazole" /><entity charOffset="46-55" id="DDI-PubMed.27119576.s15.e1" text="metformin" /><entity charOffset="60-74" id="DDI-PubMed.27119576.s15.e2" text="levonorgestrel" /><entity charOffset="75-92" id="DDI-PubMed.27119576.s15.e3" text="ethinyl estradiol" /><pair ddi="false" e1="DDI-PubMed.27119576.s15.e0" e2="DDI-PubMed.27119576.s15.e0" /><pair ddi="false" e1="DDI-PubMed.27119576.s15.e0" e2="DDI-PubMed.27119576.s15.e1" /><pair ddi="false" e1="DDI-PubMed.27119576.s15.e0" e2="DDI-PubMed.27119576.s15.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s15.e0" e2="DDI-PubMed.27119576.s15.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s15.e1" e2="DDI-PubMed.27119576.s15.e1" /><pair ddi="false" e1="DDI-PubMed.27119576.s15.e1" e2="DDI-PubMed.27119576.s15.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s15.e1" e2="DDI-PubMed.27119576.s15.e3" /><pair ddi="false" e1="DDI-PubMed.27119576.s15.e2" e2="DDI-PubMed.27119576.s15.e2" /><pair ddi="false" e1="DDI-PubMed.27119576.s15.e2" e2="DDI-PubMed.27119576.s15.e3" /></sentence><sentence text=" " /></document>